Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
about
Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Pramipexole reduces soluble mu ...... model of Huntington's disease.
@en
Pramipexole reduces soluble mu ...... model of Huntington's disease.
@nl
type
label
Pramipexole reduces soluble mu ...... model of Huntington's disease.
@en
Pramipexole reduces soluble mu ...... model of Huntington's disease.
@nl
prefLabel
Pramipexole reduces soluble mu ...... model of Huntington's disease.
@en
Pramipexole reduces soluble mu ...... model of Huntington's disease.
@nl
P2093
P50
P921
P1476
Pramipexole reduces soluble mu ...... model of Huntington's disease.
@en
P2093
Diego Luis-Ravelo
Domingo Afonso-Oramas
Héctor Estévez-Silva
Josmar Salas-Hernández
Julia Rodríguez-Núñez
Pedro Barroso-Chinea
P304
P356
10.1016/J.EXPNEUROL.2017.10.019
P407
P577
2017-10-19T00:00:00Z